1. Home
  2. WWR vs CVM Comparison

WWR vs CVM Comparison

Compare WWR & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WWR
  • CVM
  • Stock Information
  • Founded
  • WWR 1977
  • CVM 1983
  • Country
  • WWR United States
  • CVM United States
  • Employees
  • WWR N/A
  • CVM N/A
  • Industry
  • WWR Metal Mining
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WWR Basic Materials
  • CVM Health Care
  • Exchange
  • WWR Nasdaq
  • CVM Nasdaq
  • Market Cap
  • WWR 33.7M
  • CVM 35.7M
  • IPO Year
  • WWR N/A
  • CVM 1987
  • Fundamental
  • Price
  • WWR $0.54
  • CVM $0.56
  • Analyst Decision
  • WWR
  • CVM
  • Analyst Count
  • WWR 0
  • CVM 0
  • Target Price
  • WWR N/A
  • CVM N/A
  • AVG Volume (30 Days)
  • WWR 665.6K
  • CVM 459.4K
  • Earning Date
  • WWR 11-15-2024
  • CVM 12-19-2024
  • Dividend Yield
  • WWR N/A
  • CVM N/A
  • EPS Growth
  • WWR N/A
  • CVM N/A
  • EPS
  • WWR N/A
  • CVM N/A
  • Revenue
  • WWR N/A
  • CVM N/A
  • Revenue This Year
  • WWR N/A
  • CVM N/A
  • Revenue Next Year
  • WWR N/A
  • CVM $3,412.81
  • P/E Ratio
  • WWR N/A
  • CVM N/A
  • Revenue Growth
  • WWR N/A
  • CVM N/A
  • 52 Week Low
  • WWR $0.40
  • CVM $0.54
  • 52 Week High
  • WWR $0.78
  • CVM $3.23
  • Technical
  • Relative Strength Index (RSI)
  • WWR 43.21
  • CVM 14.93
  • Support Level
  • WWR $0.55
  • CVM $0.54
  • Resistance Level
  • WWR $0.60
  • CVM $0.92
  • Average True Range (ATR)
  • WWR 0.03
  • CVM 0.06
  • MACD
  • WWR -0.01
  • CVM -0.02
  • Stochastic Oscillator
  • WWR 12.70
  • CVM 5.18

About WWR Westwater Resources Inc.

Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: